Turmeric Extract (Curcumin) (Curcuma)




Scientific Effect

Turmeric is a bright orange root that contains Curcumin. It has been implicated in the control of inflammation in numerous illnesses.



Clinical Study

Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study.

Results

"Turmeric may help reduce irritable bowel syndrome symptomology."

Study Citation

Bundy, R., Walker, A. F., Middleton, R. W., & Booth, J. (2004). Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. Journal of Alternative & Complementary Medicine, 10(6), 1015-1018.

Link


Clinical Study

...curcuma decreases serum hepcidin levels in human and supports the idea that curcuma could be useful in treating hepcidin overproduction during inflammatory processes.

Results

"Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo-controlled, randomized, double-blind, cross-over study."

Study Citation

Lainé, F., Laviolle, B., Bardou‐Jacquet, E., Fatih, N., Jezequel, C., Collet, N., ... & Loréal, O. (2017). Curcuma decreases serum hepcidin levels in healthy volunteers: a placebo‐controlled, randomized, double‐blind, cross‐over study. Fundamental & clinical pharmacology, 31(5), 567-573.

Link


Clinical Study

...curcumin consumption may reduce diabetes complications through decreasing TG level as well as indicators of inflammation.

Results

"The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial."

Study Citation

Adibian, M., Hodaei, H., Nikpayam, O., Sohrab, G., Hekmatdoost, A., & Hedayati, M. (2019). The effects of curcumin supplementation on high‐sensitivity C‐reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial. Phytotherapy Research, 33(5), 1374-1383.

Link